INNOGEN-B (02591) Depositary Shares Valued at HK$188 Million; Shareholder Deposits 25.29 Million Shares with Citibank

Stock News07-31

Data from the Hong Kong Stock Exchange shows that on July 30, a significant position change occurred in INNOGEN-B (02591), with depositary shares valued at a total of HK$188 million, representing a 6.03% stake. A company shareholder deposited 25.2905 million shares into Citibank, increasing their shareholding ratio by 6.02%.

The company's financial results for the year ended December 31, 2025, indicate that the group generated approximately RMB 131.5 million in revenue, primarily from the sale of Yisupaglutide Alpha in China. The net loss stood at RMB 341 million, expanding by 95.4% year-over-year, with a basic loss per share of RMB 0.79.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment